S-1: Splash Beverage Group Files for Resale of Shares

Splash Beverage Group, Inc. has filed a Form S-1 with the SEC to register up to 5,000,000 shares of its common stock for resale by C/M Capital Master Fund, LP.

Summary

• Splash Beverage Group, Inc. (SBEV) has filed a Form S-1 with the SEC to register up to 5,000,000 shares of its common stock for resale by C/M Capital Master Fund, LP.
• The company is transitioning from a beverage business to the cannabinoid and wellness sector, with a focus on the CannEpil product.
• Splash Beverage Group is facing significant financial challenges, including a going concern warning from its auditors and non-compliance with NYSE American listing requirements.
• The company has a history of losses and negative cash flows, and relies on external financing to continue operations.
• The filing details a reverse stock split, management changes, and various legal and financial risks.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the company's ongoing financial struggles, potential delisting risks, and the dilutive nature of its financing arrangements.

Positives

• The company is actively pivoting to the cannabinoid and wellness market with the acquisition of exclusive worldwide rights to CannEpil.
• A strategic investment in Avicanna Inc. aligns with the company's new direction.
• The company has entered into a development and collaboration agreement for CannEpil's veterinary use.
• Management is actively seeking strategic transactions to improve the company's financial position and market compliance.

Negatives

• The company's auditors have raised substantial doubt about its ability to continue as a going concern.
• Splash Beverage Group has failed to meet NYSE American's stockholders' equity requirement and is under a compliance plan with a deadline of January 29, 2027.
• The company has a history of recurring losses and negative cash flows, with no revenue generated in Q2 2026.
• The company's stock price has been volatile and has traded below $0.10 per share, leading to a trading halt that was lifted by a reverse stock split.
• The company has significant outstanding debt and is reliant on future financing, which may not be available on favorable terms.
• The company has limited personnel, with only three full-time employees, and no dedicated sales and marketing staff.

Risks

• The company's ability to continue as a going concern is uncertain due to its financial condition and need for additional financing.
• Failure to regain compliance with NYSE American listing standards by January 29, 2027, could result in delisting.
• The company may be unable to raise sufficient capital to fund its operations and execute its business plan.
• The success of CannEpil is uncertain, and regulatory approvals, clinical trials, and market acceptance pose significant risks.
• The company faces substantial risks related to intellectual property protection, competition, and evolving regulations in the cannabinoid industry.
• Future sales of common stock by existing stockholders or the perception of such sales could negatively impact the stock price.
• Dilution from the issuance of additional shares of common stock, convertible securities, warrants, and options could significantly impact existing stockholders.
• The company's management must devote substantial time to public company compliance, potentially diverting attention from core business activities.

Future Outlook

The company intends to use proceeds from the equity line of credit for working capital, to resolve disputes, satisfy outstanding amounts payable, and for general corporate purposes, supporting its strategic pivot into the cannabinoid wellness market and efforts to achieve NYSE compliance. However, the company's ability to raise sufficient capital and achieve its strategic objectives remains uncertain.

Management Comments

• Management is seeking to position the Company to capitalize on the ongoing evolution of the cannabinoid and wellness economy by attempting to identify, partner with, and support established brands across the hemp-derived CBD and, subject to applicable regulatory and exchange approvals, medical cannabis marketplaces.
• Management believes the Company is uniquely positioned to capitalize on the ongoing evolution of the cannabinoid and wellness economy by identifying, partnering with, and supporting established brands across the hemp-derived CBD and, subject to applicable regulatory and exchange approvals, medical cannabis marketplaces.

Industry Context

StockSavvy.ai notes that Splash Beverage Group's pivot to the cannabinoid and wellness sector aligns with a broader industry trend of companies seeking growth in this rapidly expanding market. However, the company faces intense competition and significant regulatory hurdles, particularly in the U.S. market.

Comparison to Industry Standards

• The company's financial situation, including its going concern warning and failure to meet equity requirements, is a significant deviation from industry standards for publicly traded companies aiming for stability and growth.
• The reliance on equity lines of credit for funding is common among early-stage or distressed companies, but the terms and potential dilution are critical factors compared to more established players.
• The company's transition into the cannabinoid market mirrors a trend, but its lack of established products, significant losses, and limited personnel place it at a disadvantage compared to established cannabinoid companies like Medterra CBD (a potential acquisition target) or Trulieve (which has achieved major exchange listing).

Legal Proceedings

• TapouT, LLC filed a complaint for breach of contract seeking approximately $1,700,000.
• The company is resolving alleged claims from investors referred to as Uptime Investor Claims.
• Miguel Ramirez filed a claim for back wages and penalties totaling $44,634.70.
• Decathlon Alpha IV, L.P. issued a demand for payment of $2,833,395.98.
• Premium Merchant Funding 26, LLC obtained a default judgment of $168,777.94.
• Jeremy Reichman, Albert Reichman, Seth Yanofsky, and Daniel Braun are seeking $2,000,000 for alleged unpaid compensation.
• Copa Di Vino Corporation filed a complaint for breach of a settlement agreement, alleging approximately $788,000 in unpaid amounts.
• The company is in discussions with creditors for approximately $4.7 million in past due amounts.

Related Party Transactions

• The company sublets office space from Northswell Consulting, LLC, an entity owned by Interim CEO Brady Cobb, for $4,750 per month.
• William Meissner, former President, entered into a consulting agreement for $5,000 per month and received stock options.
• Robert Nistico, former CEO and director, entered into a consulting agreement for $5,000 per month and received stock options, and was owed $31,000 in expenses.
• The company has outstanding related party notes payable to Robert Nistico totaling $389,000 as of March 31, 2026.

Stakeholder Impact

• Existing shareholders face significant dilution risk due to potential future sales of common stock under the ELOC and the conversion of preferred stock and warrants.
• The company's precarious financial situation and potential delisting from the NYSE American pose a substantial risk to all stakeholders, potentially leading to a loss of investment.
• Employees may be impacted by the company's financial instability and the need for cost-saving measures, including potential changes in management and operations.
• Creditors and suppliers may face delays or uncertainty in receiving payments due to the company's liquidity issues.

Next Steps

• Splash Beverage Group must submit a compliance plan to the NYSE American by May 29, 2026, outlining how it will regain compliance with listing standards by January 29, 2027.
• The company is continuing discussions and negotiations for a potential merger with Medterra CBD, LLC.
• The company will proceed with the resale of up to 5,000,000 shares of common stock by C/M Capital Master Fund, LP as registered under this S-1 filing.
• The company intends to use proceeds from the ELOC for working capital and to advance its strategic pivot into the cannabinoid wellness market.

Key Dates

Recommendation

The company is in severe financial distress, facing a going concern warning, non-compliance with exchange listing requirements, and a lack of revenue. The proposed equity line of credit will likely lead to significant dilution, and the company's ability to execute its strategic pivot into the cannabinoid market is highly uncertain. The substantial risks outweigh any potential upside, making it a sell recommendation.

Keywords

Splash Beverage Group, SBEV, Form S-1, Cannabinoid, Wellness, CannEpil, Equity Line of Credit, Resale of Shares